Valuation : Virbac

Market Cap 2.71B 3.15B 2.54B 2.32B 4.37B 301B 4.38B 30.15B 11.76B 152B 11.81B 11.55B 503B P/E 2026 *
15.9x
P/E 2027 * 14.4x
Enterprise Value 2.84B 3.29B 2.66B 2.43B 4.57B 315B 4.59B 31.56B 12.31B 159B 12.36B 12.09B 527B EV / Sales 2026 *
1.83x
EV / Sales 2027 * 1.69x
Free-Float
49.03%
Yield 2026 *
0.53%
Yield 2027 * 0.63%
1 week-2.57%
Current month-4.44%
1 month-6.52%
3 months-10.04%
6 months-12.24%
Current year-9.28%
1 week 322
Extreme 322
333
1 month 322
Extreme 322
349
3 years 241
Extreme 241
394.5
5 years 216.5
Extreme 216.5
441.5
10 years 101.68
Extreme 101.682
441.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.57%-3.87%+19.67% 3.15B
+3.09%-0.50%-50.55%-59.87% 31.96B
-1.55%+0.58%+31.39%+94.44% 12.05B
+2.32%+3.89%-16.64%+9.43% 4.04B
+0.15%-2.56%-3.43%+17.42% 3.15B
-0.63%+0.08%+48.77%+34.54% 2.05B
+0.42%+2.44%+14.86%+14.20% 1.97B
+3.63%+3.72%+1.62%+154.01% 1.53B
+0.58%-3.46%-22.84%-8.27% 1.17B
+1.62%+2.68%-9.46%-40.65% 1.05B
Average +1.07%+1.45%-1.02%+23.49% 6.55B
Weighted average by Cap. +1.65%+0.36%-19.84%-5.45%

Financials

2026 *2027 *
Net sales 1.55B 1.8B 1.45B 1.33B 2.5B 172B 2.51B 17.25B 6.73B 86.83B 6.76B 6.61B 288B 1.65B 1.91B 1.54B 1.41B 2.66B 183B 2.66B 18.32B 7.15B 92.23B 7.18B 7.02B 306B
Net income 171M 199M 160M 146M 276M 18.98B 277M 1.9B 743M 9.58B 746M 729M 31.77B 190M 220M 178M 162M 306M 21.02B 307M 2.11B 823M 10.61B 826M 808M 35.19B
Net Debt 127M 147M 119M 108M 204M 14.06B 205M 1.41B 550M 7.1B 552M 540M 23.53B 75.16M 87.22M 70.47M 64.33M 121M 8.34B 122M 836M 326M 4.21B 327M 320M 13.95B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
-
Date Price Change
28/08/26 €322.50 0.00%
27/08/26 €322.50 -2.42%
26/08/26 €330.50 +0.76%
25/08/26 €328.00 -0.15%
24/08/26 €328.50 -0.76%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
323.50EUR
Average target price
411.88EUR
Spread / Average Target
+27.32%

Quarterly revenue - Rate of surprise